Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biotin for diabetic peripheral neuropathy.

D Koutsikos1, B Agroyannis, H Tzanatos-Exarchou

  • 1University of Athens, Aretaieon University Hospital, Greece.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

INR deviations in hemodialyzed patients under low dose oral anticoagulant therapy.

The International journal of artificial organs·2009
Same author

Combination of sodium thiosulphate, cinacalcet, and paricalcitol in the treatment of calciphylaxis with hyperparathyroidism.

The International journal of artificial organs·2008
Same author

Relation of interdialytic water retention with apparent bicarbonate space, HCO3-, and pH in hemodialyzed uremic patients.

Renal failure·2005
Same author

Hematocrit-lowering effect following inactivation of renin-angiotensin system with angiotensin converting enzyme inhibitors and angiotensin receptor blockers.

Current topics in medicinal chemistry·2004
Same author

Pre-HD dilution acidosis, without post-HD contraction alkalosis in uremic patients.

The International journal of artificial organs·2003
Same author

Abdominal aortic aneurysm and renal artery stenosis: renal function and blood pressure before and after endovascular treatment.

Journal of human hypertension·2002

High-dose biotin supplements significantly improved symptoms in diabetic patients with peripheral neuropathy within weeks. This suggests biotin may be crucial for managing nerve damage in diabetes, though more trials are needed.

Area of Science:

  • Biochemistry
  • Neurology
  • Metabolism

Background:

  • Diabetic peripheral neuropathy is a common complication of diabetes.
  • Biotin is a vital coenzyme for several metabolic enzymes.
  • Potential biotin deficiency or dysfunction may contribute to diabetic neuropathy.

Purpose of the Study:

  • To investigate the therapeutic effect of high-dose biotin in patients with diabetic peripheral neuropathy.
  • To explore the potential role of biotin deficiency in the pathogenesis of diabetic neuropathy.

Main Methods:

  • Three patients with severe diabetic peripheral neuropathy received high-dose biotin for 1-2 years.
  • Clinical and laboratory findings were monitored throughout the treatment period.

Main Results:

Related Experiment Videos

  • Marked improvement in clinical and laboratory findings was observed within 4-8 weeks of biotin administration.
  • Suggests a potential link between biotin status and nervous system metabolism in diabetes.

Conclusions:

  • High-dose biotin may be beneficial for the prevention and management of diabetic peripheral neuropathy.
  • Further extensive randomized clinical trials are required to confirm these findings and establish optimal dosage and duration.